Sarah Greene, MS, Chief Executive Officer, Rapid Science, Brooklyn, NY; Email sg@rapidscience.org Q: You are the leader of Rapid Science, an innovative initiative intended to speed up the process of […]
David K. Cundiff, MD, Retired internist and palliative care physician from LA County + USC Medical Center; Email: dkcundiff@whistleblowerdoctor.org. Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, […]
Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY; Email: musella@virtualtrials.com Phone: 888-295-4740 Q: You direct an established foundation that supports research and information […]
Paul R Billings MD, PhD, CEO and Chairman of Synergenz LTD Q: Lung cancer screening of smokers (spiral CT over 3 years) is paid for by CMS (reimbursement), has a […]
Smruti Vidwans, PhD, Chief Science Officer at CollabRx Q: You have been notified that your article entitled “A Melanoma Molecular Disease Model” is among the top 10% of most cited […]
Jerald P. Radich, MD, Director of the Molecular Oncology Lab at the Fred Hutchinson Cancer Research Center, and Professor of Medicine at the University of Washington School of Medicine Q: […]
Bassel El-Rayes, MD, Professor and Vice Chair for Clinical Research, Department of Hematology and Medical Oncology, Associate Director for Clinical Research, and Director of the Gastrointestinal Oncology Program Winship Cancer Institute […]
Melinda Roberts, Web and Product Development Lead Globiana Inc. Q: Many people are interested in their own genes and wonder whether they are predisposed to cancer or other maladies. You recently […]
Ivan Oransky, MD, is co-founder of Retraction Watch. Oransky is Distinguished Writer In Residence at New York University’s Arthur Carter Journalism Institute, and editor at large of MedPage Today. Adam Marcus is also […]
Keith Flaherty, MD, Associate Professor of Medicine, Harvard Medical School; Director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital Q: A lot has happened in the field of Metastatic Melanoma […]